

[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
[ Thu, Oct 13th 2022
] - WOPRAI
Matthew Harrison Maintained (ALNY) at Hold with Decreased Target to $220 on, Oct 13th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Decreased Target from $222 to $220 on, Oct 13th, 2022.
Matthew has made no other calls on ALNY in the last 4 months.
There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $200 on, Friday, September 9th, 2022
- David Lebowitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $164 on, Friday, July 15th, 2022
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Hold and Held Target at $175 on, Wednesday, July 13th, 2022
- Debjit Chattopadhyay of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, June 27th, 2022
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $98 on, Wednesday, June 15th, 2022
These are the ratings of the 5 analyists that currently disagree with Matthew
- Maury Raycroft of "Jefferies" Maintained at Strong Buy with Increased Target to $232 on, Monday, October 3rd, 2022
- Luca Issi of "RBC Capital" Maintained at Buy with Increased Target to $250 on, Tuesday, September 20th, 2022
- Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $256 on, Friday, September 9th, 2022
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $240 on, Thursday, August 4th, 2022
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $250 on, Thursday, August 4th, 2022
Contributing Sources